x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

PharmaTalkRadio

Conference Forum

PharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry insiders on the latest strategies, business models, and new innovations to advance clinical research with emphasis on clinical trials, patient- centricity, drug delivery, Immuno-oncology, digital, mobile and other technologies as well as leadership topics

science life sciences

All Episodes

40:16

What is the State of Clinical Trial Patient Matching...

PharmaTalkRadio ·

2025/12/19

About this podcast:Recorded at the 2025 DPHARM conference, this state of the union panel convenes site, technology and pharma to discuss: Different models and the pros and cons of the deployment modelsWhat makes a great patient matching solutionPredicting what the future growth of this segment looks likeThe role of AI in this space

en

45:12

Balancing Innovation and Practicality in...

PharmaTalkRadio ·

2025/12/19

About this podcast: Recorded at the 2025 IO360º Summit, this podcast addresses how Project Optimus is reshaping dose selection from maximum tolerated dose to a balance of efficacy and safety. More specifically, this panel addresses FDA objectives for multi-dose selection, alternative dose-selection strategies with imaging, biomarkers and tumor burden analysis, the higher costs and longer timelines, and financial impacts for early-phase oncology companies. For more information, go to

en

20:38

Leveraging Local HCPs to Decentralize Clinical...

PharmaTalkRadio ·

2025/12/19

About this podcast: Recorded at the 2025 CRAACO meeting, UNC Lineberger’s Comprehensive Cancer Center shares an initiative to allow local HCPs to still provide clinical care to patients but decentralized research elements to the university system, following the FDA’s change in guidance on Form FDA 1572, which stopped requiring local healthcare professionals (HCPs) involved in DCTs to be listed if they’re only performing standard-of-care. Dr J Kaitlin Morrison talks about the process from an initial

en

19:59

Using Patient Engagement and Digital Innovation to...

PharmaTalkRadio ·

2025/12/19

About this podcast:This podcast, recorded at the 2025 Patients as Partners Europe meeting, addresses how Novo Nordisk is consolidating patient insights to ensure greater knowledge-sharing, data integrity and traceability, addressing the unmet needs of patients, aligning product outcomes with patient expectations, and more. For more information, go to theconferenceforum.org.

en

5:22

What to Expect at the 2026 Patients as Partners in...

PharmaTalkRadio ·

2025/12/18

In this podcast, Kate Woda, Conference Director of the Patients as Partners in Clinical Research conference discusses what attendees can expect at the 13th annual event, including key topic areas, session highlights, presenting companies and more. For more information about the upcoming event, full agenda and speakers, visit patientsaspartnersconference.com.

en

27:50

The Role of the CMO in BD and M&A Partnering with Pharma

PharmaTalkRadio ·

2025/12/12

In this podcast, featuring a panel discussion from the 2025 Chief Medical Officer Summit 360°, CMOs with recent M&A and partnership experience share those experiences as well as how CMOs of other small to midsize emerging biotech companies can support the conversations and operations that take place throughout the process of business development. Specifically:Different kinds of BD deals to be aware ofHow the CMO fits into various phases of transactionsAppreciating how different c-suite

en

29:59

Advances in Payload Delivery and Drug Conjugation

PharmaTalkRadio ·

2025/12/12

In this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives and drug delivery experts discuss conjugation and bioconjugation approaches to make ASOs and small molecules more tolerable while improving targeting. Technologies discussed include ADCs, PDCs, SMDCs, VDCs, RDCs and AOCs. Specifically they address:Biological and chemical challenges for these therapiesBuilding out scalable manufacturing and a regulatory strategyHurdles to overcome to

en

32:20

Building Up a CMO Team as Your Company Evolves

PharmaTalkRadio ·

2025/12/01

This podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° about how to strategically approach hiring FTEs, insourcing, outsourcing and contracting to be appropriately prepared for the different stages of a biotech companies development from preclinical to early stage to late stage trials to commercialization. Specifically:Balancing the mix of hires and outsourcingHiring for skillsets to enable efficiency without overhiringReactive vs proactive hiringBuilding in a stage

en

29:52

Beyond LNPs: Delivering Genetic Medicines with Novel...

PharmaTalkRadio ·

2025/12/01

While lipid nanoparticles are the most clinically advanced drug delivery system for nucleic acid therapeutics, they are only one tool in a toolbox of potential delivery vehicles.In this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives and drug delivery experts discuss additional tools, including polymeric nanoparticles, protein-based nanoparticles and extracellular vesicles with a focus on:Where LNPs potentially fall shortWhere different

en

15:26

Pfizer on Advancing Data Analysis Capabilities...

PharmaTalkRadio ·

2025/11/24

About this podcast: This podcast comes from the DPHARM 2025 meeting. Pfizer details how they jointly co-designed and implemented an EDC/CDMS platform that’s fit for purpose, and analysis data set. This session focuses on:Engaging all stakeholders in designing the platformThe evolution of the platform focus: the transition from the majority of data coming from EDC to 3/4 of the data from third party sourcesImpact of the advanced data analysis capabilities for risk managementReview of impact on

en

16:05

Insights from Tufts CSDD into Evolving Trial...

PharmaTalkRadio ·

2025/11/24

About this podcast: Preliminary survey results conducted by the Tufts CSDD focus on the strategic and structural growth of new trial sites and partnerships in bringing trials directly to the local communities. The preliminary survey findings also shed light on the strategic and structural growth of these new trial sites and partnerships, offering valuable insights into the evolving global clinical trial landscape.The significant shift towards bringing clinical trials directly to local communities

en

19:18

ADCs, Chemotherapy, and Checkpoint Blockade in...

PharmaTalkRadio ·

2025/11/24

About this podcast:This session, from the 2025 IO360 Summit, focuses on different strategies to augment immune response in urothelial carcinoma, presented by Dr Jonathan Rosenberg, Memorial Sloan Kettering Cancer Center. Dr Rosenberg focuses on: The background and previous data of immune checkpoint blockade as monotherapy and in combination with chemotherapy, in urothelial cancerThe potential role of Immunogenic Cell Death and whether it has a clinical impact on patient care and creating an

en

18:11

Understanding the Immunological Effects of...

PharmaTalkRadio ·

2025/11/24

About this podcast:This presentation from the 2025 IO360º Summit focuses on the immunological effects of radiopharmaceuticals, presented by Chaitanya Divgi, Sr Strategic Expert, Therapeutic Innovation, at Novartis. Specifically, this podcast dives deeper into: An introduction to radioligand therapyA focus on PSMA-targeted radionuclide therapyPrelimary work on the relationship between systemic radiation therapy and immune effects at the tumor level For more information, visit IO360summit.com

en

26:00

How J&J Is Integrating Patient Centricity Across the...

PharmaTalkRadio ·

2025/11/19

About this episode:In this podcast, Dr Penny Heaton, Global Head of the Johnson and Johnson Office of the Chief Medical Officer, discusses: J&J’s approach to patient centricity across the enterpriseHer thoughts on balancing balancing safety and risk/benefit ratios with more engaged patients and more complex scienceMoving risk benefit assessments earlier into clinical development and the necessary change managementIncorporating multiple streams of data for the purpose of creating medicines that

en

31:13

Biogen's Nicole Murphy on Drug Delivery Innovation...

PharmaTalkRadio ·

2025/11/19

In this podcast, Nicole Murphy, EVP and Head of Pharmaceutical Operations & Technology at Biogen, discusses:Cross-functional collaboration to deliver valueHow Biogen is using AI to enhance innovationSupply chain simplificationBiogen's partnership philosophy as it relates to drug deliveryTheir recent $2 billion manufacturing investment in the Research Triangle ParkAnd Biogen's acquisition of Alcyone Therapeutics It's an enlightening look into what real leadership in drug delivery, manufacturing

en

4:22

What to Expect at the 2026 IO360° Summit

PharmaTalkRadio ·

2025/11/12

In this podcast, Kate Woda, Conference Director of the Immuno-Oncology 360° Summit, discusses what attendees can expect at the 12th annual event, including key topic areas, session highlights, presenting companies and more.For more information about the upcoming event, full agenda and speakers, visit IO360Summit.com.

en

30:55

CMOs Working Flexibly with Consultants and Fractional...

PharmaTalkRadio ·

2025/11/03

This podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° with CMOs and advisory solutions firms about how CMOs can work with consultants and fractional talent to stay on budget while getting the expertise needed. Specifically:Different profiles of fractional consultantsWhat to look for in a consultant and how to ensure alignment with the teamScoping the role of fractional talent and iterating as company needs evolveHow to best work with firms representing fractional

en

17:35

Principles and Strategies for Designing Best-in-Class...

PharmaTalkRadio ·

2025/10/24

About this podcast:This podcast dives deep into the fundamentals of antibody-drug conjugate design, specifically focusing on the selection of targeting antibodies, cytotoxic drugs, and linkers. Presenter Dr Deepa Pakianathan highlights key strategies for constructing ADCs and the critical differentiating features that enhance therapeutic efficacy and safety. For more information, go to IO360summit.com.

en

41:58

How Patient Organizations are Bridging Patient...

PharmaTalkRadio ·

2025/10/24

About this podcast:This podcast comes from the 2025 Patients as Partners in Clinical Research conference. This panel discussion demonstrates how patient advocates are bridging the divide at the site level to improve patient representation in clinical trials. More specifically, this podcast focuses on: Strategies for overcoming limited resources and lack of infrastructure, which can hinder inclusive clinical trial participationSuccessful models for empowering local leaders and leveraging

en

13:08

How Roche Reduced Unnecessary Protocol Amendments to...

PharmaTalkRadio ·

2025/10/21

About this podcast: Liz Thompson, Global Development Leader, Senior Clinical Development Scientist at Roche, presented how the organization had delivered a single, cohesive protocol amendment categorization process to reduce the number of amendments and create a continuous improvement strategy, all to speed up timelines and reduce costs. This presentation comes from the September 2025 DPHARM: Disruptive Innovations to Modernize Clinical Research program. More specifically, Ms Thompson discusses how

en

69 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter